Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer - Concepedia

Concepedia

Publication | Open Access

Selective Inhibition of ADAM Metalloproteases as a Novel Approach for Modulating ErbB Pathways in Cancer

DOI Full Paper Access

143

Citations

36

References

2007

Year

Jordan S. Fridman, Eian Caulder, Michael Hansbury, Xiangdong Liu, Genjie Yang, Qian Wang, Yvonne Lo, Bin‐Bing S. Zhou, Maxwell Pan, Sufi M. Thomas,

Clinical Cancer Research

Abstract

Inhibition of ErbB ligand shedding offers a potentially novel and well-tolerated therapeutic strategy for the treatment of human cancers and is currently being evaluated in the clinic.

References

	Year	Citations

Page 1